HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic.

Abstract
In this double blind, prospective study, the relative efficacy of Diclofenac + Pitofenone + Fenpiverinium (Manyana) and Analgin + Pitofenone + Fenpiverinium (Baralgan) in 200 patients of biliary, ureteric and intestinal colic was evaluated. Patients were given these coded drugs thrice daily for five days starting from day 0 to day 5. The results of the present clinical evaluation demonstrated that Manyana appeared to be superior to Baralgan in biliary and ureteric colic while it was therapeutically equivalent to Baralgan in reducing the pain intensity in intestinal colic. Both the medications were tolerated well and there were no side-effects reported.
AuthorsA Chaudhary, R L Gupta
JournalJournal of the Indian Medical Association (J Indian Med Assoc) Vol. 97 Issue 6 Pg. 244-5 (Jun 1999) ISSN: 0019-5847 [Print] India
PMID10645700 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzophenones
  • Drug Combinations
  • Parasympatholytics
  • Piperidines
  • manyana
  • Diclofenac
  • Dipyrone
  • fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination
Topics
  • Adolescent
  • Adult
  • Benzophenones (therapeutic use)
  • Biliary Tract Diseases (drug therapy)
  • Colic (diagnosis, drug therapy)
  • Diclofenac (therapeutic use)
  • Dipyrone (therapeutic use)
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Humans
  • Intestinal Diseases (drug therapy)
  • Male
  • Middle Aged
  • Pain Measurement
  • Parasympatholytics (therapeutic use)
  • Piperidines (therapeutic use)
  • Prospective Studies
  • Time Factors
  • Ureteral Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: